Order Article Reprints

Okada A, Niki R, Inoue Y, Tomita J, Todo H, Itakura S, Sugibayashi K. Development of Self-Administered Formulation to Improve the Bioavailability of Leuprorelin Acetate. Pharmaceutics. 2022; 14(4):785. https://doi.org/10.3390/pharmaceutics14040785

Okada, Akie, Rina Niki, Yutaka Inoue, Junki Tomita, Hiroaki Todo, Shoko Itakura, and Kenji Sugibayashi. 2022. "Development of Self-Administered Formulation to Improve the Bioavailability of Leuprorelin Acetate" Pharmaceutics 14, no. 4: 785. https://doi.org/10.3390/pharmaceutics14040785

Okada, A., Niki, R., Inoue, Y., Tomita, J., Todo, H., Itakura, S., & Sugibayashi, K. (2022). Development of Self-Administered Formulation to Improve the Bioavailability of Leuprorelin Acetate. Pharmaceutics, 14(4), 785. https://doi.org/10.3390/pharmaceutics14040785